J&J gets FDA okay for psoriasis drug icotrokinra Johnson & Johnson's much-anticipated oral IL-23 drug, icotrokinra, has claimed FDA approval as Icotyde for first-line treatment of plaque psoriasis.

#JohnsonandJohnson's much-anticipated oral IL-23 inhibitor, #icotrokinra, has claimed #FDAapproval as a first-line treatment for #plaquepsoriasis.

Line graphs show proportion of patients reporting no symptoms through 1 year and 1-3 years. Graphs show data for no itching, no skin pain and no scaling for Bimekizumab & Secukinumab treatments. Bimekizumab every 4 wk/8 wk, %(n=177) text@1 to text@2.

Bimekizumab provided rapid and sustained improvements in symptoms and quality of life for patients with moderate to severe #PlaquePsoriasis, with benefits maintained through 3 years.

ja.ma/4rtcgJT

Line graphs show proportion of patients reporting no symptoms through 1 year and 1-3 years. Graphs show data for no itching, no skin pain and no scaling for Bimekizumab & Secukinumab treatments. Bimekizumab every 4 wk/8 wk, %(n=177) text@1 to text@2.

Bimekizumab provided rapid and sustained improvements in symptoms and quality of life for patients with moderate to severe #PlaquePsoriasis, with benefits maintained through 3 years.

ja.ma/3ZF5S63

Call for patient input on roflumilast (Zoryve®) for plaque psoriasis - Arthritis News If you are a patient or caregiver of someone living with plaque psoriasis, we want to hear from you!

JointHealth™ express - Call for patient input on roflumilast (Zoryve®) for plaque psoriasis. Send your input to feedback@jointhealth.org.

Learn more: bit.ly/JHECDAPatien...

#patientinput #plaquepsoriasis

#biosimilars #PolpharmaBiologics #MSPharma #gastroenterology #neurology #dermatology #MENA #vedolizumab #ocrelizumab #guselkumab #ulcerativecolitis #Crohnsdisease #multiplesclerosis #plaquepsoriasis #psoriaticarthritis #biosimilarmanufacturing #MS #PolpharmaBiologicsGroup
zurl.co/GJnQQ

Stada revives talk of an IPO – if conditions improve Germany's Stada has said it may make another attempt to seek a public listing in the autumn, after delaying its plans earlier this year.

#Stada #IPO #pharmaindustry #generics #OTC #specialtymedicines #rarediseases #chronicdiseases #biosimilars #plaquepsoriasis #psoriaticarthritis #Crohnsdisease #specialtybiosimilars #aflibercept #denosumab #golimumab #tocilizumab #blockbusterdrugs #GLP1agonists #diabetes #obesity
zurl.co/nbsw4

MHRA approves guselkumab for Crohn’s disease and ulcerative colitis - PharmaTimes Regulator confirms safety and efficacy of new treatment option for patient

#gastroenterology #MHRA #guselkumab #Tremfya #jmj #janssen #Crohnsdisease #ulcerativecolitis #plaquepsoriasis #psoriaticarthritis #activeCrohnsdisease #Clinicalstudies #Crohnsdiseasepatients #guselkumabtreatment
pharmatimes.com/news/mhra-ap...

Humira: Navigating Savings Options NeedyMeds lists programs to help cover the cost of Humira, with insurance or not. We're going to discuss common programs we refer people to.

We get a lot of calls about Humira, so this week’s #blog breaks down the savings options we recommend. blog.needymeds.org/2024/11/26/h...

#humira #biosimilar #autoimmunedisease #inflamatoryboweldisease #plaquepsoriasis #ankylosingspondylitis #amyloidosis #rheumatoidarthritis #psoriasiswarrior